samarium has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bohlen, H; Diehl, V; Engert, A; Hertel, M; Hippler-Altenburg, R; Manzke, O; Tesch, H | 1 |
1 other study(ies) available for samarium and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Differentiation of cytotoxicity using target cells labelled with europium and samarium by electroporation.
Topics: Cell Line; Cytotoxicity Tests, Immunologic; Electroporation; Europium; Evaluation Studies as Topic; Humans; In Vitro Techniques; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Leukemia, Lymphocytic, Chronic, B-Cell; Pentetic Acid; Samarium | 1994 |